SWTX (SpringWorks Therapeutics) - Bullish end to Quarter
SPRINGWORKS THERAPEUTICS INC.
SpringWorks Therapeutics Inc. is a clinical-stage biopharmaceutical company. It is focused on developing life-changing medicines for patients with severe rare diseases and cancer. The company's product pipeline consists of Nirogacestat and Mirdametinib which are in clinical stage. SpringWorks Therapeutics Inc. is based in Stamford, United States.
Analysis/Commentary
New business, so lots of unknowns, but potential to the upside
Based on the study of the previous quarterly earnings reports and subsequent price moves:
- Current quarter has given price move below LOW point
- Buy opportunity in place
- Expectation for the price to move back to LOW or MID point
- Trailing stop-loss on price above LOW point
GOOD LUCK.
DO YOUR OWN RESEARCH!
SpringWorks Therapeutics Inc. is a clinical-stage biopharmaceutical company. It is focused on developing life-changing medicines for patients with severe rare diseases and cancer. The company's product pipeline consists of Nirogacestat and Mirdametinib which are in clinical stage. SpringWorks Therapeutics Inc. is based in Stamford, United States.
Analysis/Commentary
New business, so lots of unknowns, but potential to the upside
Based on the study of the previous quarterly earnings reports and subsequent price moves:
- Current quarter has given price move below LOW point
- Buy opportunity in place
- Expectation for the price to move back to LOW or MID point
- Trailing stop-loss on price above LOW point
GOOD LUCK.
DO YOUR OWN RESEARCH!
Hold to quarter end for potential break-even